Clarus Wealth Advisors Gilead Sciences, Inc. Transaction History

Clarus Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	SELL	$63.47 - $69.35 $569,516 - $622,277	-8,973 Closed	0 $0
Q3 2019 Oct 11, 2019	BUY	$62.51 - $69.0 $557,589 - $615,480	8,920 Added 16830.19%	8,973 $569,000
Q4 2018 Jan 08, 2019	BUY	$60.54 - $79.0 $3,208 - $4,187	53 New	53 $4,000
Q4 2018 Jan 07, 2019	SELL	$60.54 - $79.0 $3,208 - $4,187	-53 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$71.28 - $78.92 $71 - $78	1 Added 1.92%	53 $4,000
Q2 2018 Jul 05, 2018	BUY	$64.88 - $75.68 $3,373 - $3,935	52 New	52 $4,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.